STATE STREET CORP - SPECTRUM PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
STATE STREET CORP ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$588,450
+16.2%
612,969
-9.2%
0.00%
Q1 2023$506,527
+19.8%
675,369
-41.2%
0.00%
Q4 2022$422,942
+57.8%
1,147,738
+84.1%
0.00%
Q3 2022$268,000
-52.4%
623,569
-13.6%
0.00%
Q2 2022$563,000
-86.9%
721,769
-78.4%
0.00%
Q1 2022$4,306,000
-28.5%
3,338,316
-29.6%
0.00%
Q4 2021$6,024,000
-83.9%
4,743,039
-72.3%
0.00%
-100.0%
Q3 2021$37,358,000
-11.1%
17,136,619
+53.0%
0.00%0.0%
Q2 2021$42,000,000
-1.9%
11,200,031
-14.7%
0.00%0.0%
Q1 2021$42,793,000
+18.5%
13,126,592
+24.0%
0.00%0.0%
Q4 2020$36,101,000
+28.6%
10,586,684
+53.9%
0.00%0.0%
Q3 2020$28,066,000
+22.4%
6,878,822
+1.4%
0.00%0.0%
Q2 2020$22,935,000
+87.4%
6,785,536
+29.2%
0.00%
+100.0%
Q1 2020$12,238,000
-30.6%
5,252,365
+8.5%
0.00%0.0%
Q4 2019$17,625,000
-51.1%
4,842,001
+11.4%
0.00%
-66.7%
Q3 2019$36,041,000
-18.1%
4,344,953
-15.0%
0.00%0.0%
Q2 2019$44,008,000
-24.2%
5,111,276
-5.8%
0.00%
-40.0%
Q1 2019$58,027,000
+13.1%
5,428,184
-7.4%
0.01%0.0%
Q4 2018$51,291,000
-48.9%
5,861,781
-1.9%
0.01%
-37.5%
Q3 2018$100,406,000
-9.2%
5,976,812
+13.3%
0.01%
-11.1%
Q2 2018$110,570,000
+40.9%
5,275,272
+8.2%
0.01%
+28.6%
Q1 2018$78,470,000
+0.7%
4,876,778
+18.6%
0.01%
+16.7%
Q4 2017$77,931,000
+100.9%
4,112,737
+49.2%
0.01%
+100.0%
Q3 2017$38,783,000
+72.3%
2,756,436
-8.7%
0.00%
+50.0%
Q2 2017$22,507,000
+47.1%
3,020,563
+28.3%
0.00%
+100.0%
Q1 2017$15,305,000
+113.3%
2,353,958
+45.3%
0.00%0.0%
Q4 2016$7,177,000
-36.5%
1,620,307
-33.0%
0.00%0.0%
Q3 2016$11,294,000
-11.5%
2,419,125
+24.6%
0.00%0.0%
Q2 2016$12,759,000
+63.6%
1,942,050
+58.3%
0.00%0.0%
Q1 2016$7,798,000
-53.2%
1,226,504
-55.6%
0.00%
-50.0%
Q4 2015$16,665,000
-42.9%
2,763,699
-43.4%
0.00%
-33.3%
Q3 2015$29,193,000
-14.9%
4,881,744
-2.6%
0.00%
-25.0%
Q2 2015$34,297,000
+20.9%
5,014,140
+7.3%
0.00%
+33.3%
Q1 2015$28,367,000
+21.1%
4,672,874
+38.2%
0.00%
+50.0%
Q4 2014$23,433,000
-4.9%
3,381,609
+11.8%
0.00%
-33.3%
Q3 2014$24,631,000
+8.9%
3,025,675
+8.7%
0.00%
+50.0%
Q2 2014$22,625,000
-14.3%
2,782,779
-17.3%
0.00%
-33.3%
Q1 2014$26,387,000
-51.8%
3,365,468
-38.4%
0.00%0.0%
Q4 2013$54,762,000
+93.8%
5,460,133
+62.1%
0.00%0.0%
Q3 2013$28,255,000
+6.9%
3,367,775
-4.9%
0.00%0.0%
Q2 2013$26,423,0003,542,1880.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,020,583$15,053,0001.77%
Piermont Capital Management Inc. 247,882$1,847,0000.53%
BARD ASSOCIATES INC 129,380$964,0000.44%
Sonora Investment Management, LLC 239,202$1,782,055,0000.34%
TFS CAPITAL LLC 97,526$727,0000.28%
Alambic Investment Management, L.P. 165,001$1,229,0000.15%
KENNEDY CAPITAL MANAGEMENT LLC 491,075$3,659,0000.07%
Renaissance Technologies 6,071,817$45,235,0000.06%
Granite Investment Partners, LLC 97,023$723,0000.05%
ClariVest Asset Management LLC 241,909$1,802,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders